Conference Reports

American Headache Society (AHS) 2020 Virtual Annual Scientific Meeting

San Diego, California
13 June 2020 - 13 June 2020

American Academy of Neurology (AAN) 2020 Annual Meeting

Toronto, Ontario
25 April 2020 - 01 May 2020

International Stroke Conference (ISC) 2020

Los Angeles, California
19 February 2020 - 21 February 2020

Alzheimer's Association International Conference (AAIC) 2019

Los Angeles, California, US
14 July 2019 - 18 July 2019

2019 American Academy of Neurology (AAN) Annual Meeting

Philadelphia, Pennsylvania
04 May 2019 - 10 May 2019

American Association for Cancer Research (AACR) Annual Meeting 2019

Atlanta, Georgia
29 March 2019 - 03 April 2019

14th International Symposium on Healthy Aging

16 March 2019 - 17 March 2019

International Stroke Conference 2019 (ISC 2019)

Honolulu, Hawaii, US
06 February 2019 - 08 February 2019

Advances in Medicine 2017

19 May 2018 - 20 May 2018

2018 American Academy of Neurology Annual Meeting (AAN 2018)

Los Angeles, California, US
21 April 2018 - 27 April 2018

International Stroke Conference 2018 (ISC 2018)

Los Angeles, California, US
24 January 2018 - 26 January 2018
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Stephen Padilla, 2 days ago
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.